Michael Schreck
Known title: Executive Vice PresidentCIK: 0002004990
Associated companies
Transaction History
| IDXX | ▲ Buy | Option Exercise | 117 | $0 | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 169 | $0 | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 301 | $0 | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 367 | $0 | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 1,005 | $0 | 2/14/2026 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 876 | $551K | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 80 | $0 | 2/14/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 117 | $0 | 2/14/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 791 | $0 | 2/14/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 170 | $0 | 2/14/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 301 | $0 | 2/14/2025 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 441 | $196K | 2/14/2025 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 164 | $0 | 9/1/2024 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 48 | $23K | 9/1/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 80 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 118 | $0 | 2/14/2024 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 170 | $0 | 2/14/2024 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 117 | $66K | 2/14/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
KeyBanc initiates IDEXX coverage with Sector Weight rating
KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.
KeyBanc initiates IDEXX coverage with Sector Weight rating. KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.